Mekinist pediatric dry syrup 4.7mg

Mekinist (trametinib) pediatric dry syrup, 4.7mg (YJ code: 4291047R1022, standard: 4.7 mg, 1 bottle), manufactured by Novartis Pharma, is a MEK inhibitor used in combination with dabrafenib (Tafinlar) for the treatment of certain BRAF V600 gene mutation-positive low-grade glioma and solid tumors in children aged 1 year and older. This targeted therapy works by blocking specific proteins to help keep cancer cells from growing.